546 related articles for article (PubMed ID: 16855190)
1. Cholesteryl ester transfer protein in metabolic syndrome.
Sandhofer A; Kaser S; Ritsch A; Laimer M; Engl J; Paulweber B; Patsch JR; Ebenbichler CF
Obesity (Silver Spring); 2006 May; 14(5):812-8. PubMed ID: 16855190
[TBL] [Abstract][Full Text] [Related]
2. The Taq1B-variant in the cholesteryl ester-transfer protein gene and the risk of metabolic syndrome.
Sandhofer A; Tatarczyk T; Laimer M; Ritsch A; Kaser S; Paulweber B; Ebenbichler CF; Patsch JR
Obesity (Silver Spring); 2008 Apr; 16(4):919-22. PubMed ID: 18239576
[TBL] [Abstract][Full Text] [Related]
3. Cholesteryl ester transfer protein TaqIB polymorphism and its relation to parameters of the insulin resistance syndrome in an Austrian cohort.
Weitgasser R; Galvan G; Malaimare L; Derflinger I; Hedegger M; Lang J; Iglseder B; Ladurner G; Paulweber B
Biomed Pharmacother; 2004 Dec; 58(10):619-27. PubMed ID: 15589073
[TBL] [Abstract][Full Text] [Related]
4. Diet and waist-to-hip ratio: important predictors of lipoprotein levels in sedentary and active young men with no evidence of cardiovascular disease.
Mansfield E; McPherson R; Koski KG
J Am Diet Assoc; 1999 Nov; 99(11):1373-9. PubMed ID: 10570674
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels.
Davidson MH; McKenney JM; Shear CL; Revkin JH
J Am Coll Cardiol; 2006 Nov; 48(9):1774-81. PubMed ID: 17084249
[TBL] [Abstract][Full Text] [Related]
6. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
Misra KB; Endemann SW; Ayer M
Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
[TBL] [Abstract][Full Text] [Related]
7. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects.
Ambrosch A; Mühlen I; Kopf D; Augustin W; Dierkes J; König W; Luley C; Lehnert H
Diabetes Care; 1998 Dec; 21(12):2077-84. PubMed ID: 9839097
[TBL] [Abstract][Full Text] [Related]
8. CETP and oxidized LDL levels increase in dyslipidemic subjects.
Wang J; Gu Q; Li K; Zhang C
Clin Biochem; 2007 Sep; 40(13-14):995-9. PubMed ID: 17658505
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study.
Boekholdt SM; Kuivenhoven JA; Wareham NJ; Peters RJ; Jukema JW; Luben R; Bingham SA; Day NE; Kastelein JJ; Khaw KT
Circulation; 2004 Sep; 110(11):1418-23. PubMed ID: 15337694
[TBL] [Abstract][Full Text] [Related]
10. On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study).
Khera AV; Wolfe ML; Cannon CP; Qin J; Rader DJ
Am J Cardiol; 2010 Aug; 106(4):451-6. PubMed ID: 20691300
[TBL] [Abstract][Full Text] [Related]
11. [Body fat distribution: its characteristics and relationship to cardiovascular risk factors in obese Chinese].
Ran XW; Li XS; Tong NW; Li QF; Tang BD; Li XJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):699-703. PubMed ID: 15460424
[TBL] [Abstract][Full Text] [Related]
12. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
Kimura H; Miyazaki R; Imura T; Masunaga S; Shimada A; Mikami D; Kasuno K; Takahashi N; Hirano T; Yoshida H
Nephrology (Carlton); 2011 Aug; 16(6):558-66. PubMed ID: 21352420
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.
Goff DC; D'Agostino RB; Haffner SM; Otvos JD
Metabolism; 2005 Feb; 54(2):264-70. PubMed ID: 15690322
[TBL] [Abstract][Full Text] [Related]
14. High serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarction.
Zeller M; Masson D; Farnier M; Lorgis L; Deckert V; Pais de Barros JP; Desrumaux C; Sicard P; Grober J; Blache D; Gambert P; Rochette L; Cottin Y; Lagrost L
J Am Coll Cardiol; 2007 Nov; 50(20):1948-55. PubMed ID: 17996559
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women.
El ayachi M; Mziwira M; Vincent S; Defoort C; Portugal H; Lairon D; Belahsen R
Eur J Clin Nutr; 2005 Dec; 59(12):1379-86. PubMed ID: 16118656
[TBL] [Abstract][Full Text] [Related]
16. Elevated HDL2-paraoxonase and reduced CETP activity are associated with a dramatically lower ratio of LDL-cholesterol/total cholesterol in a hypercholesterolemic and hypertriglyceridemic patient.
Lee JH; Park JH; Lee SH; Kim JR; Cho KH
Int J Mol Med; 2010 Jun; 25(6):945-51. PubMed ID: 20428800
[TBL] [Abstract][Full Text] [Related]
17. The association of HDL cholesterol concentration with the -629C>A CETP promoter polymorphism is not fully explained by its relationship with plasma cholesteryl ester transfer.
Dullaart RP; Borggreve SE; Hillege HL; Dallinga-Thie GM
Scand J Clin Lab Invest; 2008; 68(2):99-105. PubMed ID: 17852818
[TBL] [Abstract][Full Text] [Related]
18. No physical activity x CETP 1b.-629 interaction effects on lipid profile.
Bernstein MS; Costanza MC; James RW; Morris MA; Cambien F; Raoux S; Morabia A
Med Sci Sports Exerc; 2003 Jul; 35(7):1124-9. PubMed ID: 12840632
[TBL] [Abstract][Full Text] [Related]
19. Increased serum cholesteryl ester transfer protein in obese children.
Asayama K; Hayashibe H; Dobashi K; Uchida N; Nakane T; Kodera K; Shirahata A
Obes Res; 2002 Jun; 10(6):439-46. PubMed ID: 12055319
[TBL] [Abstract][Full Text] [Related]
20. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency.
Moriyama Y; Okamura T; Inazu A; Doi M; Iso H; Mouri Y; Ishikawa Y; Suzuki H; Iida M; Koizumi J; Mabuchi H; Komachi Y
Prev Med; 1998; 27(5 Pt 1):659-67. PubMed ID: 9808796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
